Suppr超能文献

髂总静脉和髂股静脉支架置入术治疗肿瘤压迫继发的梗阻

Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression.

作者信息

Aly Ahmed K, Moussa Amgad M, Chevallier Olivier, Kishore Sirish, Petre Elena, Friedman Adie, Bryce Yolanda, Gonzalez Adrian, Camacho Juan, Santos Ernesto, Ridouani Fourat

机构信息

Radiology, Division of Interventional Radiology, MedStar Health, Baltimore, USA.

Radiology, Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.

出版信息

CVIR Endovasc. 2024 Mar 22;7(1):33. doi: 10.1186/s42155-024-00438-6.

Abstract

BACKGROUND

Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients.

METHODS

IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure.

RESULTS

Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients. Twenty-nine patients (78%, 95% CI 62-90%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58-5.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2-25 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation.

CONCLUSION

Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression.

摘要

背景

患有盆腔腹部肿块的癌症患者可能因静脉受压而出现下肢症状。静脉支架置入术已被证实对诸如May-Thurner综合征等良性疾病的外在性静脉压迫有效。在这项回顾性研究中,我们评估了下腔静脉、髂腔静脉和髂股静脉支架置入术对癌症患者恶性肿块所致外在性静脉压迫病例的疗效和安全性。

方法

对2018年1月至2022年2月期间接受髂股静脉造影、血管成形术和支架置入术的患者进行了经机构审查委员会批准的回顾性研究。纳入由恶性肿块导致外在性静脉压迫的患者。收集了患者人口统计学数据、术前症状、手术技术、支架特征、结果及随访情况。采用描述性统计来评估手术的技术成功率、临床成功率、支架初始通畅率及不良事件。

结果

纳入了37例患者(19例男性,18例女性),共进行了45例手术。21例(57%)患者存在深静脉血栓形成(DVT)。29例患者(78%,95%可信区间62 - 90%)报告其当前症状有临床改善。术后总体生存期中位数为4.7个月(95%可信区间3.58 - 5.99)。8例(22%)患者在最后一次随访时仍存活,中位随访时间为10.33个月(范围2 - 25个月)。26例患者在最后一次随访影像检查时支架通畅(70%,95%可信区间61% - 91%)。2例患者出现小的穿刺部位血肿,均自行消退。2例患者出现中度、1例患者出现与术后治疗性抗凝相关的严重不良事件。

结论

静脉支架置入术是一种安全的手术,对于患有与髂腔静脉和髂股静脉压迫相关的使人衰弱的下肢症状的患者,应将其视为姑息治疗的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62b/10957860/9be2630fa937/42155_2024_438_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验